Polymyositis Clinical Trials Polymyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: KZR-616;   Drug: Placebo Sponsor:   Kezar Life Sciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2019 Category: Research Source Type: clinical trials